DWA
ABMD

Dorsey Wright & Associates’s Abiomed Inc ABMD Stock Holding History

Dorsey Wright & Associates’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-7,141
Closed -$2.04M – 346
2019
Q1 		$2.04M Sell
7,141
-563
-7% -$187K 0.49% 85
2018
Q4 		$2.5M Sell
7,704
-17,447
-69% -$6.06M 0.75% 66
2018
Q3 		$11.3M Sell
25,151
-1,518
-6% -$598K 2.06% 5
2018
Q2 		$10.9M Sell
26,669
-16,987
-39% -$6.15M 1.6% 17
2018
Q1 		$12.7M Buy
43,656
+778
+2% +$197K 1.96% 9
2017
Q4 		$8.04M Buy
42,878
+15,106
+54% +$2.82M 1.45% 16
2017
Q3 		$4.68M Buy
+27,772
New +$4.2M 1.08% 34

Other funds holding ABMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
Amundi Asset Management US
Amundi Asset Management US Boston, Massachusetts $131B AUM 73.57% 1-Year Est. Return

Dorsey Wright & Associates's ABMD Position: Q2 2019 in Review

Dorsey Wright & Associates sold out of Abiomed Inc (ABMD) in Q2 2019, closing a stake of 7,141 shares — an estimated $2.04M sold.

Dorsey Wright & Associates first reported a position in ABMD in Q3 2017 and held it in 7 quarters. The position peaked at $12.7M in Q1 2018. 484 funds tracked by Wall St. Rank hold ABMD as of Q2 2019.

  • Dorsey Wright & Associates reported no remaining Abiomed Inc position as of Q2 2019 after selling out during the quarter.
  • Dorsey Wright & Associates sold 7,141 Abiomed Inc shares in Q2 2019, an estimated $2.04M.
  • Dorsey Wright & Associates first reported a position in Abiomed Inc in Q3 2017 and held it in 7 quarters.
  • Dorsey Wright & Associates's Abiomed Inc position peaked at $12.7M in Q1 2018.
  • 484 funds tracked by Wall St. Rank held Abiomed Inc as of Q2 2019.

Based on Dorsey Wright & Associates's 13F filing for Q2 2019, filed 2 Jul 2019.